Shaping the Future

Boehringer Ingelheim Vetmedica, Inc. is shaping the future of equine health by actively pursuing new vaccines and therapies that improve the lives of horses. Through our continuous investment in research, we’re advancing the diagnosis, treatment and understanding of equine diseases. In the past 10 years, no other animal health company has brought more products to market than us. And in the next 10 years, we plan to do even more.

BIVI Equine Headlines Wins Prestigious Media Award
Equine publication professionals recognized the BIVI IDPPID website at the 2016 annual American Horse Publications Media Awards as best in the equine-related website class. The site is designed to help both horse owners and veterinarians easily identify the signs of Pituitary Pars Intermedia Dysfunction, formerly known as equine Cushing’s disease. Visit the site at, and see how BIVI is helping shape the future of equine health.

Have you seen the signs of PPID?
The early clinical signs of Pituitary Pars Intermedia Dysfuntion (PPID), also known as equine Cushing’s disease, can be subtle. Take advantage of our testing offer this spring. Veterinarians can request up to 3 free tests from Boehringer Ingelheim Vetmedica, Inc for horses suspected to have PPID.

2016 Equine Research Award Recipients Announced
The awards were announced at the recent American Association of Equine Practitioners Annual Convention in Las Vegas. Each researcher will receive a grant of $15,000 in support of their study proposal.

Second Veterinary Technician Champion of the Cause Award Winner Selected
The second Champion of the Cause Award winner, Claudia Cary Davidson, is an equine veterinary technician at Fowlerville Veterinary Clinic in Fowlerville, Michigan. Davidson was nominated by Dean Gibbons, DVM.

Cases more common in even well-vaccinated horses
Data from research on recent equine influenza virus (EIV) outbreaks show a noticeable change in the horses being affected by the virus.

Reducing equine respiratory virus spread
Reducing the spread of equine respiratory viruses is key to equine health however, some of these viruses can be difficult to eliminate and some can lead to explosive outbreaks.

Pregnant mare label claim for Vetera® Vaccines
USDA approves study data, making BIVI vaccines the only vaccines on the market labeled for use in pregnant mares

Timeline of products

How our products are shaping the future
of equine health


PRASCEND is the first and only medicine available in the United States that is approved by the FDA to treat pituitary pars intermedia dysfunction (PPID), historically termed “equine Cushing’s disease,” in horses.

Important Safety Information

PRASCEND has not been evaluated in breeding, pregnant, or lactating horses and may interfere with reproductive hormones in these horses. See complete prescribing information.


Following the recommendation of the Expert Survellence Panel on Equine Influenza, Vetera vaccines protect from flu strains most likely to infect horses today.